NCT06192745

Brief Summary

The proposed project aims to disentangle the impact of evening light exposure emitted from tablet devices from the impact of arousing media content on children's sleep regulation, circadian physiology and next-day emotion regulation and executive functioning.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
28mo left

Started Jan 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Jan 2025Aug 2028

First Submitted

Initial submission to the registry

December 12, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
1 year until next milestone

Study Start

First participant enrolled

January 10, 2025

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2028

Last Updated

May 9, 2025

Status Verified

May 1, 2025

Enrollment Period

3.6 years

First QC Date

December 12, 2023

Last Update Submit

May 6, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Differences in Sleep Duration on nights following the experimental and internal negative control exposures

    Children will wear an Actiwatch Spectrum watch (Philips Respironics, Inc.) on the wrist of their non-dominant hand. Total sleep time are the total minute of sleep scored as sleep by the Sadeh algorithm between sleep onset and sleep offset.

    Night 9 and 16

  • Differences in Subjective Sleep Quality on nights following the experimental and internal negative

    Visual analog scales will be used to collect subjective ratings of sleep quality and morning alertness the morning following the study condition. Participants will be asked to rate the quality of their sleep last night (very poor to very good), how difficult was it for them to wake up this morning (very easy to very hard), and how alert do you feel right now (wide awake to very sleepy).

    Night 9 and 16

Secondary Outcomes (12)

  • Differences in the change in circadian phase

    night 8 to night 10 and night 15 to night 17

  • Differences in Sleep Latency on nights following the experimental and internal negative control exposures

    Night 9 and 16

  • Differences in Heart Rate during the experimental and internal negative exposures

    Night 9 and 16

  • Differences in Heart Rate Variability during the experimental and internal negative exposures

    Night 9 and 16

  • Differences in Pre-sleep arousal scale following the the experimental and internal negative exposures

    Night 9 and 16

  • +7 more secondary outcomes

Other Outcomes (9)

  • Ambient Light Exposure

    Days 1-17

  • Average daily duration of Tablet use (excluding the experimental exposures)

    Days 1-17

  • Other Screen Media Use

    Days 1-17

  • +6 more other outcomes

Study Arms (4)

Group 1

EXPERIMENTAL

Children will participate in 2 exposure conditions in their own homes (i.e., experimental and internal negative control), facilitated by research staff (one week apart, counterbalanced to control for possible order effects). The internal negative control will be the same for all groups, but the experimental exposure will differ. Both exposures will take place for 1 hour before bed in room lighting (40-50 lux). Experimental exposure: children in Group 1 will be exposed to a tablet with unfiltered bright screen light and exciting media content (BL/EC). Internal negative control exposure: children will participate in non-screen-based quiet activities

Behavioral: no screen control with dim light and calming activitiesBehavioral: unfiltered Bright tablet screenBehavioral: Exciting content

Group 2

EXPERIMENTAL

Children will participate in 2 exposure conditions in their own homes (i.e., experimental and internal negative control), facilitated by research staff (one week apart, counterbalanced to control for possible order effects). The internal negative control will be the same for all groups, but the experimental exposure will differ. Both exposures will take place for 1 hour before bed in room lighting (40-50 lux). Experimental exposure: children in Group 2 will be exposed to a tablet with unfiltered bright screen light and calming media content (BL/CC). Internal negative control exposure: children will participate in non-screen-based quiet activities

Behavioral: no screen control with dim light and calming activitiesBehavioral: unfiltered Bright tablet screenBehavioral: Calming Content

Group 3

EXPERIMENTAL

Children will participate in 2 exposure conditions in their own homes (i.e., experimental and internal negative control), facilitated by research staff (one week apart, counterbalanced to control for possible order effects). The internal negative control will be the same for all groups, but the experimental exposure will differ. Both exposures will take place for 1 hour before bed in room lighting (40-50 lux). Experimental exposure: children in Group 3 will be exposed to a tablet with filtered dim screen light and exciting media content (DL/EC). Internal negative control exposure: children will participate in non-screen-based quiet activities

Behavioral: no screen control with dim light and calming activitiesBehavioral: Filtered dim tablet screenBehavioral: Exciting content

Group 4

EXPERIMENTAL

Children will participate in 2 exposure conditions in their own homes (i.e., experimental and internal negative control), facilitated by research staff (one week apart, counterbalanced to control for possible order effects). The internal negative control will be the same for all groups, but the experimental exposure will differ. Both exposures will take place for 1 hour before bed in room lighting (40-50 lux). Experimental exposure: children in Group 4 will be exposed to a tablet with filtered dim screen light and calming media content (DL/CC). Internal negative control exposure: children will participate in non-screen-based quiet activities

Behavioral: no screen control with dim light and calming activitiesBehavioral: Filtered dim tablet screenBehavioral: Calming Content

Interventions

Non-screen-based quiet activities for 1 hour before bed in room lighting 40-50 lux

Also known as: internal negative control
Group 1Group 2Group 3Group 4

Bright light screen media exposure will be delivered on an iPad Pro provided by the research team which will be set to the brightest light intensity setting for 1 hour before bed in room lighting 40-50 lux

Group 1Group 2

Filtered dim light screen media exposure will be delivered for 1 hour before bed in room lighting 40-50 lux on an iPad Pro provided by the research team. A blue light filter will be used to alter the spectral distribution of the emitted light and the screen brightness will be dimmed to the lowest possible setting

Group 3Group 4

We will create a 1-hour recording of movie clips containing exciting content from age-appropriate movies for 8- to 11-year-old children as rated by Common Sense Media.

Group 1Group 3
Calming ContentBEHAVIORAL

We will create a 1-hour recording of movie clips containing calming content from age-appropriate movies for 8- to 11-year-old children as rated by Common Sense Media.

Group 2Group 4

Eligibility Criteria

Age8 Years - 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • children between 8.0 and 11.9 year old
  • Tanner stage 1 and 2
  • live with their parent(s) (biological or legal guardian at least 50% of the time and has a primary role of caring for the child).
  • Children who sleep between 8.5 to 11 hours per night habitually
  • Children must sleep alone most nights
  • parent and child able to communicate and read and write in English
  • The child does not have to have access to a mobile device (tablet or Phone), but if they do, the primary device they use has to be an a) Android OS ≥5.0 either used only by the study child or shared with others, b) Amazon Fire OS ≥5.0 that only the child uses or c) an Apple iOS ≥14.0 that only the child uses.
  • If the child's primary device is a Android or Amazon Fired device, the parent and child agree to install Chronicle App (Android or Amazon). If the child's primary device is an Apple device, the parent and child agree to allow us to gather usage screenshots from the primary iPad or iPhone.
  • Families must live in the greater Houston area.

You may not qualify if:

  • child blindness or colorblindness
  • significant vision problems
  • developmental or cognitive delays
  • diagnosis of a sleep or psychiatric disorder
  • diagnosed cognitive or learning impairment affecting executive functioning (e.g., attention deficit hyperactivity disorder)
  • medical conditions that impact sleep
  • taking medications that impact sleep
  • travel beyond 2 time zones in the month before starting the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Nutrition Research Center

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Emotional Regulation

Condition Hierarchy (Ancestors)

Self-ControlSocial BehaviorBehavior

Study Officials

  • Jennette P Moreno, PhD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR
  • Candice A Alfano, PhD

    University of Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Insia Raza, MPH

CONTACT

Hafza Dadabhoy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The investigators will be blinded to treatment condition in the analysis of outcomes
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 12, 2023

First Posted

January 5, 2024

Study Start

January 10, 2025

Primary Completion (Estimated)

August 30, 2028

Study Completion (Estimated)

August 30, 2028

Last Updated

May 9, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Data will be deposited in the National Institute of Child Health and Human Development-maintained Data and Specimen Hub (DASH) data repository.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data will be made available for a minimum of 3 years following the closeout of the grant, though data will be retained at Baylor College of Medicine for a minimum of 7 years following the close-out of the study.
Access Criteria
Access to the data will be controlled by the repository.

Locations